Document Detail

Buprenorphine use in pregnancy: a survey of the knowledge and opinions of obstetricians.
MedLine Citation:
PMID:  24770259     Owner:  NLM     Status:  In-Data-Review    
INTRODUCTION: There are 57,000 opiate-exposed pregnancies every year in the United States. Buprenorphine is a promising therapy for opiate addiction during pregnancy, but there have been no investigations to date to determine the position of obstetricians regarding buprenorphine. This study surveyed obstetricians to assess their knowledge of buprenorphine and their current practices with the therapy.
METHODS: This observational study was performed using in-person and electronic surveys consisting of 26 questions that assessed obstetricians' knowledge, opinions, and current practices with buprenorphine.
RESULTS: One hundred ninety-one obstetricians completed the survey: 83% female, 72% residents, 20% maternal-fetal medicine, with a median age of younger than 30 years. The majority (55%) felt that opiate addiction is a moderate problem in their community, whereas 30% perceived a severe problem. Nearly all were cognizant of buprenorphine for opiate replacement (93%), 72% correctly categorized the drug as category C, and 76% correctly identified the mechanism of action. The majority (54%) had no interest in becoming a prescriber and suggested that addiction medicine specialists would be the best providers to care for women during pregnancy (55%). Obstetricians surveyed supported a policy giving pregnant women priority on waiting lists for therapy (74% supportive and 22% unsure).
CONCLUSION: Obstetricians were knowledgeable regarding buprenorphine therapy and perceived opiate addiction to be a moderate to severe problem. They were not interested in becoming prescribers of buprenorphine; rather, obstetricians felt that addiction medicine specialists should be managing patients' opiate replacement therapy during pregnancy and support policy giving pregnant women priority on waiting lists for treatment.
Lauren A Miller
Related Documents :
6627659 - Serum lactic dehydrogenase (sldh) activity in maternal and cord blood in anemia of preg...
19297419 - Altered activity of lysophospholipase d, which produces bioactive lysophosphatidic acid...
2788219 - Modulation of the immunosuppressive activities by blastocoelic fluid during rabbit preg...
16524719 - Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor t...
19936969 - Complement activation and pregnancy failure.
25434079 - Noise exposure during pregnancy, birth outcomes and fetal development: meta-analyses us...
7189999 - Plasma infusion for thrombotic thrombocytopenic purpura during pregnancy.
15636989 - Acute pulmonary edema in the post partum and cor triatriatum sinistrum.
10099999 - Once-a-month treatment with a combination of mifepristone and the prostaglandin analogu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  123 Suppl 1     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-04-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  71S-2S     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Choice of cesarean delivery in operative vaginal delivery candidates based on physician instrument p...
Next Document:  Elective induction of nulliparous labor at 39 weeks of gestation: a randomized clinical trial.